Home
NAGE
NAGE News

Latest Niagen Bioscience Inc. Common Stock (NAGE) News on October 9, 2025

MT Newswires

3 days ago

Niagen Bioscience Raises Fiscal 2025 Net Sales Growth Outlook; Shares Up Pre-Bell

Niagen Bioscience Increases Full Year 2025 Net Sales Outlook to 25% to 30% Year-Over-Year Growth

Business Wire

3 days ago

Niagen Bioscience Increases Full Year 2025 Net Sales Outlook to 25% to 30% Year-Over-Year Growth

AboutNADⓇ Debuts as the Leading Online Resource for Scientific Advancements in NAD+

Business Wire

23 days ago

AboutNADⓇ Debuts as the Leading Online Resource for Scientific Advancements in NAD+

Three Growth Stocks With Strong Insider Commitment

Simply Wall St.

a month ago

Three Growth Stocks With Strong Insider Commitment

Even though Niagen Bioscience (NASDAQ:NAGE) has lost US$55m market cap in last 7 days, shareholders are still up 623% over 3 years

Simply Wall St.

4 months ago

Even though Niagen Bioscience (NASDAQ:NAGE) has lost US$55m market cap in last 7 days, shareholders are still up 623% over 3 years

Niagen Bioscience to Participate at the Roth 15th Annual London Conference

Business Wire

4 months ago

Niagen Bioscience to Participate at the Roth 15th Annual London Conference

Niagen Bioscience to Participate in the BIO 2025 International Convention

Business Wire

4 months ago

Niagen Bioscience to Participate in the BIO 2025 International Convention

Niagen Bioscience Announces First-Ever Peer-Reviewed Study Highlighting the Potential of Nicotinamide Riboside (NR) for Werner Syndrome, a Rare Genetic Disorder

Business Wire

4 months ago

Niagen Bioscience Announces First-Ever Peer-Reviewed Study Highlighting the Potential of Nicotinamide Riboside (NR) for Werner Syndrome, a Rare Genetic Disorder

Niagen Bioscience to Present at Oppenheimer’s 25th Annual Consumer Growth and E-Commerce Conference

Business Wire

4 months ago

Niagen Bioscience to Present at Oppenheimer’s 25th Annual Consumer Growth and E-Commerce Conference

3 Growth Companies With High Insider Ownership And Up To 18% Revenue Growth

Simply Wall St.

4 months ago

3 Growth Companies With High Insider Ownership And Up To 18% Revenue Growth

3 Stocks That May Be Trading Below Their Estimated Value

Simply Wall St.

5 months ago

3 Stocks That May Be Trading Below Their Estimated Value

Exploring May 2025's Undervalued Small Caps With Insider Action

Simply Wall St.

5 months ago

Exploring May 2025's Undervalued Small Caps With Insider Action

Niagen Bioscience First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

5 months ago

Niagen Bioscience First Quarter 2025 Earnings: Beats Expectations

Niagen Bioscience Inc (NAGE) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com

5 months ago

Niagen Bioscience Inc (NAGE) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Niagen Bioscience, Inc. Reports First Quarter 2025 Financial Results and Increases Outlook

Business Wire

5 months ago

Niagen Bioscience, Inc. Reports First Quarter 2025 Financial Results and Increases Outlook

Niagen Bioscience Announces Pharmaceutical-Grade Niagen® IV Is Now Available in Almost 600 Clinics Nationwide

Business Wire

5 months ago

Niagen Bioscience Announces Pharmaceutical-Grade Niagen® IV Is Now Available in Almost 600 Clinics Nationwide

Three High Growth Companies Insiders Are Eager To Hold

Simply Wall St.

5 months ago

Three High Growth Companies Insiders Are Eager To Hold

Niagen Bioscience Welcomes Dr. Pinchas Cohen to Scientific Advisory Board

Business Wire

5 months ago

Niagen Bioscience Welcomes Dr. Pinchas Cohen to Scientific Advisory Board

Niagen Bioscience to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025

Business Wire

5 months ago

Niagen Bioscience to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025

Niagen Bioscience, Inc.'s (NASDAQ:NAGE) market cap up US$51m last week, benefiting both individual investors who own 36% as well as insiders

Simply Wall St.

6 months ago

Niagen Bioscience, Inc.'s (NASDAQ:NAGE) market cap up US$51m last week, benefiting both individual investors who own 36% as well as insiders

Niagen Bioscience Confirms Its Operations Remain Unaffected by New Tariffs

Business Wire

6 months ago

Niagen Bioscience Confirms Its Operations Remain Unaffected by New Tariffs

Growth Companies With High Insider Ownership For April 2025

Simply Wall St.

6 months ago

Growth Companies With High Insider Ownership For April 2025

A Look At The Fair Value Of Niagen Bioscience, Inc. (NASDAQ:NAGE)

Simply Wall St.

6 months ago

A Look At The Fair Value Of Niagen Bioscience, Inc. (NASDAQ:NAGE)

Why ChromaDex Corp (CDXC) Is Surging In 2025?

Insider Monkey

6 months ago

Why ChromaDex Corp (CDXC) Is Surging In 2025?

Share on Social Networks: